Biosensors Market – Global Forecast To 2030
바이오센서 시장 – 유형(센서 패치, 임베디드 디바이스), 제품(웨어러블, 비웨어러블), 웨어러블(리스트웨어, 바디웨어), 기술(전기화학, 광학, 압전, 열, 나노기계), 애플리케이션 및 지역별 – 2030년까지의 세계 예측
Biosensors Market by Type (Sensor Patch, Embedded Device), Product (Wearable, Non-Wearable), Wearable (Wristwear, Bodywear), Technology (Electrochemical, Optical, Piezoelectric, Thermal, Nanomechanical), Application and Region – Global Forecast to 2030
| 조사회사 | MarketsandMarkets |
| 출판년월 | 2025년7월 |
| 페이지 수 | 228 |
| 도표 수 | 255 |
| 라이센스 | Single User License |
| 가격 | USD 4,950 |
| 구성 | 영문조사보고서 |
본 연구 보고서는 바이오센서 시장을 유형(센서 패치, 내장형 기기), 제품(웨어러블, 비웨어러블), 기술(전기화학, 광학, 압전, 열, 나노기계), 구성 요소(바이오수용체 분자, 생물학적 요소, 트랜스듀서), 응용 분야(POC, 홈 진단, 연구실, 환경 모니터링, 식음료, 바이오디펜스), 지역(북미, 유럽, 아시아 태평양, RoW)을 기준으로 분류합니다. 본 보고서는 바이오센서 시장과 관련된 주요 성장 동력, 제약, 과제, 기회를 설명하고 2030년까지의 전망을 제시합니다. 또한, 바이오센서 생태계에 포함된 모든 기업에 대한 리더십 매핑 및 분석도 포함하고 있습니다.
The global biosensors market is expected to reach USD 34.51 billion in 2025 from USD 54.37 billion by 2030, growing at a CAGR of 9.5% during this period. Market growth is driven by the rising number of infectious diseases in developing countries, increasing demand for rapid diagnosis and efficient monitoring solutions, and technological advancements such as miniaturization, nanotechnology, microfluidics, and new product innovations. Additionally, the growing demand in urban areas, where diagnostic devices are easily accessible and simple to use, is further boosting market growth. Governments worldwide are launching initiatives to improve diagnostics and drug services, aiming to ensure availability and access to diagnostic testing while reducing patients’ out-of-pocket expenses.
세계 바이오센서 시장은 2030년 543억 7천만 달러에서 2025년 345억 1천만 달러로 성장할 것으로 예상되며, 이 기간 동안 연평균 9.5% 성장할 것으로 예상됩니다. 시장 성장은 개발도상국의 감염병 증가, 신속한 진단 및 효율적인 모니터링 솔루션에 대한 수요 증가, 그리고 소형화, 나노기술, 미세유체공학, 신제품 혁신과 같은 기술 발전에 힘입어 촉진되고 있습니다. 또한, 진단 장비의 접근성과 사용이 간편한 도시 지역의 수요 증가는 시장 성장을 더욱 가속화하고 있습니다. 전 세계 각국 정부는 진단 및 약물 서비스 개선을 위한 다양한 계획을 시행하고 있으며, 환자의 본인 부담금을 줄이는 동시에 진단 검사의 접근성을 확보하기 위해 노력하고 있습니다.
“Embedded devices to account for the larger market share in 2030”
Embedded devices are commonly used in various applications such as point of care, home diagnostics, food and beverages, research labs, environmental monitoring, and biodefense. With the growth of the Internet of Things (IoT) devices, there has been a significant shift in connected healthcare applications. IoT enables real-time alerts, tracking, and monitoring, which allows for hands-on treatments, improved accuracy, timely interventions by doctors, and overall better patient care. Many healthcare facilities are beginning to adopt embedded solutions for medical devices with IoT capabilities to address the shortage of doctors in remote areas. These IoT-enabled medical devices help identify diseases and perform various tests to deliver accurate and reliable treatment to patients in remote locations. Consequently, the increasing use of embedded devices will boost the market growth of biosensors.
“Non-wearable (POC) biosensors to capture the largest share of the biosensors market throughout the forecast period”
The non-wearable biosensors market is a vibrant growth area driven by diverse applications, from handheld tools to lab systems and point-of-care diagnostics, vital in healthcare, environmental monitoring, and food safety. These biosensors, used in hospitals, research, food, and environmental sectors, enable real-time, on-site monitoring, helping address food quality challenges and meet safety standards. Market growth is fueled by increased awareness of environmental surveillance and the need for rapid devices for biodefense, food control, and pathogen detection.
“China to hold largest share in Asia Pacific of biosensors market in 2030”
The factors driving the biosensors market in China include rapid economic growth and an aging population, along with government efforts to improve healthcare services. Many multinational exporters and producers operating in China have adopted strategies such as acquisitions or strategic partnerships that support reliable domestic distribution and service infrastructure. In contrast, many domestic manufacturers, particularly those focused on export markets outside of China, lack strong distribution and service networks within the country. China is the most populous country in the world, and with the one-child policy, the elderly population is expected to increase in the future. As the population ages, there will likely be a significant rise in the incidence of various disorders, including heart diseases.
Extensive primary interviews were conducted with key industry experts in the biosensors market to determine and verify the market size for various segments and subsegments gathered through secondary research. The breakdown of primary participants for the report is shown below: The study includes insights from various industry experts, from component suppliers to Tier 1 companies and OEMs. The breakdown of the primary participants is as follows:
- By Company Type: Tier 1–40%, Tier 2–35%, and Tier 3–25%
- By Designation: C-level Executives–45%, Directors–35%, and Others–20%
- By Region: North America–30%, Europe–22%, Asia Pacific–40%, and RoW–8%
Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), and ACON Laboratories (US) are some key players in the biosensors market.
The study includes an in-depth competitive analysis of these key players in the biosensors market, with their company profiles, recent developments, and key market strategies.
Study Coverage: This research report categorizes the biosensors market based on type (sensor patches, embedded devices), product (wearable, non-wearable), technology (electrochemical, optical, piezoelectric, thermal, nanomechanical), component (bioreceptor molecules, biological elements, transducers), application (POC, home diagnostics, research labs, environmental monitoring, food & beverages, biodefense), and region (North America, Europe, Asia Pacific and RoW). The report describes the major drivers, restraints, challenges, and opportunities pertaining to the biosensors market and forecasts the same till 2030. The report also consists of leadership mapping and analysis of all the companies included in the biosensor ecosystem.
Key Benefits of Buying the Report The report will help the market leaders/new entrants in this market by providing information on the closest approximations of the revenue numbers for the overall biosensors market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (emergence of nanotechnology-based biosensors, technological advancements, increasing use of biosensors to monitor glucose levels in individuals with diabetes, government initiatives to support diagnostics) restraints (reluctance to adopt new treatment practices, high costs of R&D), opportunities (emerging markets in developing countries, food & environmental monitoring applications, growth opportunities in wearables) and challenges (regulatory barriers and long certification & approval cycles) influencing the growth of the biosensors market
- Product Development/Innovation: Detailed insights into upcoming technologies, research and development activities, and the latest product and service launches in the biosensors market
- Market Development: Comprehensive information about lucrative markets – the report analyzes the biosensors market across varied regions
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the biosensors market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), and ACON Laboratories (US) in the biosensors market
Table of Contents
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS AND EXCLUSIONS 24
1.3 STUDY SCOPE 24
1.3.1 MARKETS & REGIONS COVERED 24
1.3.2 YEARS CONSIDERED 25
1.3.3 CURRENCY CONSIDERED 25
1.3.4 UNITS CONSIDERED 25
1.4 STAKEHOLDERS 25
1.5 SUMMARY OF CHANGES 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
2.1.1 SECONDARY DATA 28
2.1.1.1 List of major secondary sources 28
2.1.1.2 Key data from secondary sources 29
2.1.2 PRIMARY DATA 29
2.1.2.1 List of primary interview participants 29
2.1.2.2 Key data from primary sources 30
2.1.2.3 Breakdown of primaries 30
2.1.2.4 Key industry insights 31
2.1.3 SECONDARY AND PRIMARY RESEARCH 31
2.2 MARKET SIZE ESTIMATION METHODOLOGY 32
2.2.1 BOTTOM-UP APPROACH 32
2.2.2 TOP-DOWN APPROACH 33
2.2.2.1 Approach to derive market size (supply side) 33
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 35
2.4 RESEARCH ASSUMPTIONS 36
2.5 RESEARCH LIMITATIONS 36
2.6 RISK ANALYSIS 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 42
4.1 ATTRACTIVE OPPORTUNITIES IN BIOSENSORS MARKET 42
4.2 BIOSENSORS MARKET FOR WEARABLE DEVICES, BY TYPE 42
4.3 BIOSENSORS MARKET IN NORTH AMERICA, BY COUNTRY AND BY PRODUCT 43
4.4 BIOSENSORS MARKET, BY COUNTRY 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
5.2.1 DRIVERS 45
5.2.1.1 Emergence of nanotechnology-based biosensors 45
5.2.1.2 Technological advancements in recent years 46
5.2.1.3 Increasing use of biosensors to monitor glucose levels in individuals with diabetes 46
5.2.1.4 Supportive government initiatives for diagnostics 46
5.2.2 RESTRAINTS 47
5.2.2.1 Reluctance to adopt new treatment practices 47
5.2.2.2 High cost of biosensor R&D 47
5.2.3 OPPORTUNITIES 48
5.2.3.1 Emerging markets in developing countries 48
5.2.3.2 Rising food and environmental monitoring applications 48
5.2.3.3 Growth opportunities in wearables 49
5.2.4 CHALLENGES 49
5.2.4.1 Regulatory barriers and long certification & approval cycles 49
5.3 VALUE CHAIN ANALYSIS 50
5.4 ECOSYSTEM ANALYSIS 51
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 53
5.6 PRICING ANALYSIS 54
5.6.1 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEMS,
BY PRODUCT TYPE, 2025 54
5.6.2 INDICATIVE SELLING PRICE OF GLUCOSE MONITORING SYSTEMS,
BY COMPANY, 2025 54
5.6.3 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEMS,
BY REGION 55
5.7 TECHNOLOGY ANALYSIS 56
5.7.1 KEY TECHNOLOGIES 56
5.7.1.1 Multiplexed Biosensors 56
5.7.2 COMPLEMENTARY TECHNOLOGIES 56
5.7.2.1 AI-Integrated Biosensing Platforms 56
5.7.3 ADJACENT TECHNOLOGIES 56
5.7.3.1 Drug Delivery Systems 56
5.8 CASE STUDY ANALYSIS 57
5.8.1 CASE STUDY 1: I-STAT SYSTEM HELPS PATIENTS AT ROCHDALE URGENT CARE CENTER 57
5.8.2 CASE STUDY 2: INTEGRATED HEALTH SOLUTION PROVIDED COST SAVINGS AND INCREASED EFFICIENCY 58
5.8.3 CASE STUDY 3: IMPROVING MOBILITY FOR PATIENTS AND REDUCING FALSE ALARMS FOR STAFF AT SUB-ACUTE CHILDREN’S HOSPITAL 58
5.8.4 CASE STUDY 4: ENABLING SEAMLESS DATA TRANSMISSION
FROM PATIENT’S HOME 59
5.9 INVESTMENT AND FUNDING SCENARIO 59
5.10 IMPACT OF GEN AI/AI ON BIOSENSORS MARKET 60
5.11 PATENT ANALYSIS 61
5.12 TRADE ANALYSIS 64
5.13 PORTER’S FIVE FORCES ANALYSIS 67
5.13.1 INTENSITY OF COMPETITIVE RIVALRY 68
5.13.2 THREAT OF SUBSTITUTES 68
5.13.3 BARGAINING POWER OF BUYERS 68
5.13.4 BARGAINING POWER OF SUPPLIERS 68
5.13.5 THREAT OF NEW ENTRANTS 69
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 69
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 69
5.14.2 BUYING CRITERIA 70
5.15 KEY CONFERENCES AND EVENTS, 2025–2026 71
5.16 REGULATORY LANDSCAPE AND STANDARDS 72
5.16.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
5.16.2 STANDARDS 74
5.17 IMPACT OF 2025 US TARIFFS—BIOSENSORS MARKET 76
5.17.1 INTRODUCTION 76
5.17.2 KEY TARIFF RATES 76
5.17.3 PRICE IMPACT ANALYSIS 78
5.17.4 IMPACT ON COUNTRIES/REGIONS 78
5.17.4.1 US 78
5.17.4.2 Europe 78
5.17.4.3 Asia Pacific 79
5.17.5 IMPACT ON APPLICATIONS 79
5.17.5.1 Point of Care (PoC) 79
5.17.5.2 Home Diagnostics 79
6 BIOSENSORS MARKET, BY COMPONENT 80
6.1 INTRODUCTION 80
6.2 BIORECEPTOR MOLECULES 80
6.2.1 ANTIBODIES AND PROTEINS ARE ALSO USED AS BIORECEPTOR MOLECULES IN BIOSENSORS 80
6.3 BIOLOGICAL ELEMENTS 80
6.3.1 BIOLOGICAL ELEMENTS ARE MATERIALS RELATED TO BIOMOLECULES 80
6.4 TRANSDUCERS 81
6.4.1 TRANSDUCER CONVERTS BIOCHEMICAL ACTIVITIES INTO ELECTRICAL SIGNALS 81
7 BIOSENSORS MARKET, BY TYPE 82
7.1 INTRODUCTION 83
7.2 SENSOR PATCHES 84
7.2.1 WIDE-RANGE MONITORING OF VITAL SIGNS AND OTHER REQUIRED PARAMETERS 84
7.3 EMBEDDED DEVICES 84
7.3.1 BROAD-SPECTRUM DETECTION OF BIOLOGICAL ANALYTES, HIGH SUCCESS RATES IN MEDICAL LABS AND FOOD BIOANALYSES 84
8 BIOSENSORS MARKET, BY PRODUCT 85
8.1 INTRODUCTION 86
8.2 WEARABLE BIOSENSORS 87
8.2.1 WRISTWEAR 90
8.2.1.1 Real-time health and fitness tracking and monitoring 90
8.2.2 EYEWEAR 90
8.2.2.1 Smart glasses and smart lenses to have significant presence in market in coming years 90
8.2.3 FOOTWEAR 90
8.2.3.1 Help in monitoring kilometers run, calories burned, workout hours, blood pressure, and other fitness & health-related data 90
8.2.4 NECKWEAR 91
8.2.4.1 Trendy devices that can help monitor fitness and health 91
8.2.5 BODYWEAR 91
8.2.5.1 Have potential to equip clothes used for daily wear with smart capabilities, making detection of body movements possible 91
8.2.6 OTHER WEARABLE BIOSENSORS 91
8.3 NON-WEARABLE (POC) BIOSENSORS 91
8.3.1 REAL-TIME ON-SITE MONITORING OF PRODUCTION PROCESSES 91
9 BIOSENSORS MARKET, BY TECHNOLOGY 94
9.1 INTRODUCTION 95
9.2 ELECTROCHEMICAL BIOSENSORS 96
9.2.1 AMPEROMETRIC SENSORS 97
9.2.1.1 Blood glucose sensors 97
9.2.1.1.1 Suitable for medical devices for monitoring blood glucose 97
9.2.2 POTENTIOMETRIC SENSORS 97
9.2.2.1 Immunosensors 98
9.2.2.1.1 Label-free detection and quantification of immune complex 98
9.2.3 CONDUCTOMETRIC SENSORS 98
9.2.3.1 Studies in enzymatic reactions and practical applications such as drug and pollutant detection to propel market 98
9.3 OPTICAL BIOSENSORS 98
9.3.1 SPR BIOSENSORS 99
9.3.1.1 Measure interactions in real-time with high sensitivity and without needing labels 99
9.3.2 COLORIMETRIC BIOSENSORS 99
9.3.2.1 Used in various applications, such as detection and identification of virulence activities 99
9.3.3 FLUORESCENCE BIOSENSORS 100
9.3.3.1 Provide better sensitivities and specificities, as well as ease of labeling, while detection 100
9.4 PIEZOELECTRIC BIOSENSORS 100
9.4.1 ACOUSTIC BIOSENSORS 101
9.4.1.1 Monitor changes in physical properties of acoustic waves in response to measurand 101
9.4.2 MICROCANTILEVER BIOSENSORS 101
9.4.2.1 Promising tool for detecting biomolecular interactions with improved accuracy 101
9.5 THERMAL BIOSENSORS 102
9.5.1 STABILITY, NO NEED FOR FREQUENT RECALIBRATION, AND INSENSITIVITY TO OPTICAL AND ELECTROCHEMICAL PROPERTIES SUPPORT ADOPTION 102
9.6 NANOMECHANICAL BIOSENSORS 103
9.6.1 RAPID, SENSITIVE, AND SELECTIVE DETECTION OF BIOLOGICAL AND BIOCHEMICAL ENTITIES 103
10 BIOSENSORS MARKET, BY APPLICATION 104
10.1 INTRODUCTION 105
10.2 POC 106
10.2.1 GLUCOSE MONITORING 111
10.2.1.1 Rising prevalence of diabetes, advancements in self-monitoring, and growing awareness about PoC testing 111
10.2.2 CARDIAC MARKER DETECTION 111
10.2.2.1 Sedentary urban lifestyles driving prevalence of cardiovascular diseases 111
10.2.3 INFECTIOUS DISEASE DETECTION 111
10.2.3.1 Detection of toxins, bacteria, and viruses in physiological and environmental matrices 111
10.2.4 COAGULATION MONITORING 112
10.2.4.1 Growing use of anticoagulant therapy, coupled with adoption of self-testing kits for use at home 112
10.2.5 PREGNANCY TESTING 112
10.2.5.1 Growing preference of women for confidentiality and accessibility of test results 112
10.2.6 BLOOD GAS & ELECTROLYTE DETECTION 112
10.2.6.1 Growing global aging population to drive market 112
10.2.7 TUMOR/CANCER MARKER DETECTION 112
10.2.7.1 Increasing number of people suffering from cancer and growth in investments in cancer research 112
10.2.8 URINALYSIS TESTING 113
10.2.8.1 Rising number of urinary tract infections among individuals 113
10.2.9 CHOLESTEROL TESTING 113
10.2.9.1 Increasing prevalence of CVDs due to aging and obese population 113
10.3 HOME DIAGNOSTICS 113
10.3.1 GLUCOSE MONITORING 117
10.3.1.1 Growing preference for self-monitoring blood glucose devices 117
10.3.2 PREGNANCY TESTING 117
10.3.2.1 Need for portable and user-friendly pregnancy testing devices 117
10.3.3 CHOLESTEROL TESTING 118
10.3.3.1 Growth of diseases due to increased cholesterol levels in individuals 118
10.4 RESEARCH LABS 118
10.4.1 NEED FOR BIOSENSOR-BASED PRODUCT DEVELOPMENT FOR EARLY MONITORING OF DISEASES 118
10.5 ENVIRONMENTAL MONITORING 121
10.5.1 DETECTION OF CONTAMINANTS IN COMPLEX MATRICES WITH SEVERAL ADVANTAGES TO ENHANCE MARKET GROWTH 121
10.6 FOOD & BEVERAGES 125
10.6.1 BIOSENSORS USED FOR PATHOGEN DETECTION TO HELP MEET STRINGENT FOOD STANDARDS 125
10.7 BIODEFENSE 129
10.7.1 USE OF BIOSENSORS TO DETECT MICROBIAL PATHOGENS DURING BIOLOGICAL WARFARE 129
11 BIOSENSORS MARKET, BY REGION 133
11.1 INTRODUCTION 134
11.2 NORTH AMERICA 135
11.2.1 US 138
11.2.1.1 Availability of and interest in biosensor-based POC to drive market 138
11.2.2 CANADA 138
11.2.2.1 Increasing government support to propel market growth 138
11.2.3 MEXICO 138
11.2.3.1 Use of biosensors for detecting cardiovascular disorders to propel market growth in Mexico 138
11.3 EUROPE 139
11.3.1 GERMANY 142
11.3.1.1 Monitoring chronic diseases to escalate biosensors market growth 142
11.3.2 FRANCE 142
11.3.2.1 Technological advancements in healthcare systems to drive growth 142
11.3.3 UK 142
11.3.3.1 Rising cardiac diseases and aging population to drive market 142
11.3.4 ITALY 142
11.3.4.1 Growing private sector results in increasing demand for biosensors for various applications 142
11.3.5 REST OF EUROPE 143
11.4 ASIA PACIFIC 143
11.4.1 CHINA 145
11.4.1.1 Government initiatives for enhancing healthcare products and services to propel market growth 145
11.4.2 JAPAN 146
11.4.2.1 Increase in standard of living, rising health awareness, and surge in aging population to support market growth 146
11.4.3 INDIA 146
11.4.3.1 Growing population in India to escalate demand for biosensors in healthcare 146
11.4.4 REST OF ASIA PACIFIC 146
11.5 REST OF THE WORLD 147
11.5.1 SOUTH AMERICA 148
11.5.1.1 Growing environment-related concerns have boosted adoption of biosensors for environmental monitoring 148
11.5.2 MIDDLE EAST 148
11.5.2.1 Government and private support to drive adoption of POC testing kits will favor demand for biosensors 148
11.5.2.2 GCC Countries 149
11.5.2.2.1 Saudi Arabia 149
11.5.2.2.2 UAE 150
11.5.2.2.3 Rest of GCC Countries 150
11.5.2.3 Rest of Middle East 150
11.5.3 AFRICA 150
11.5.3.1 Increasing penetration in consumer electronics and medical devices 150
12 COMPETITIVE LANDSCAPE 151
12.1 OVERVIEW 151
12.2 STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2024 151
12.3 REVENUE ANALYSIS, 2022–2024 152
12.4 MARKET SHARE ANALYSIS, 2024 153
12.5 COMPANY VALUATION AND FINANCIAL METRICS 156
12.6 BRAND/PRODUCT COMPARISON 157
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 157
12.7.1 STARS 158
12.7.2 EMERGING LEADERS 158
12.7.3 PERVASIVE PLAYERS 158
12.7.4 PARTICIPANTS 158
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 160
12.7.5.1 Company footprint 160
12.7.5.2 Region footprint 161
12.7.5.3 Product footprint 162
12.7.5.4 Type footprint 163
12.7.5.5 Technology footprint 164
12.7.5.6 Application footprint 165
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 166
12.8.1 PROGRESSIVE COMPANIES 166
12.8.2 RESPONSIVE COMPANIES 166
12.8.3 DYNAMIC COMPANIES 166
12.8.4 STARTING BLOCKS 166
12.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 168
12.8.5.1 Detailed list of key startups/SMEs 168
12.8.5.2 Competitive benchmarking of key startups/SMEs 168
12.9 COMPETITIVE SCENARIO 169
12.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 169
12.9.2 DEALS 170
12.9.3 EXPANSIONS 172
13 COMPANY PROFILES 173
13.1 KEY PLAYERS 173
13.1.1 ABBOTT LABORATORIES 173
13.1.1.1 Business overview 173
13.1.1.2 Products/Solutions/Services offered 174
13.1.1.3 Recent developments 175
13.1.1.3.1 Product enhancements 175
13.1.1.3.2 Deals 176
13.1.1.4 MnM view 176
13.1.1.4.1 Key strengths/Right to win 176
13.1.1.4.2 Strategic choices 176
13.1.1.4.3 Weaknesses/Competitive threats 177
13.1.2 F. HOFFMANN-LA ROCHE LTD 178
13.1.2.1 Business overview 178
13.1.2.2 Products/Solutions/Services offered 179
13.1.2.3 Recent developments 180
13.1.2.3.1 Deals 180
13.1.2.4 MnM view 180
13.1.2.4.1 Key strengths/Right to win 180
13.1.2.4.2 Strategic choices 181
13.1.2.4.3 Weaknesses/Competitive threats 181
13.1.3 MEDTRONIC 182
13.1.3.1 Business overview 182
13.1.3.2 Products/Services/Solutions offered 183
13.1.3.3 Recent developments 184
13.1.3.3.1 Product approvals 184
13.1.3.3.2 Deals 184
13.1.3.4 MnM view 185
13.1.3.4.1 Key strengths/Right to win 185
13.1.3.4.2 Strategic choices 185
13.1.3.4.3 Weaknesses/Competitive threats 185
13.1.4 BIO-RAD LABORATORIES, INC. 186
13.1.4.1 Business overview 186
13.1.4.2 Products/Solutions/Services offered 187
13.1.4.3 MnM view 188
13.1.4.3.1 Key strengths/Right to win 188
13.1.4.3.2 Strategic choices 188
13.1.4.3.3 Weaknesses/Competitive threats 188
13.1.5 DUPONT 189
13.1.5.1 Business overview 189
13.1.5.2 Products/Solutions/Services offered 190
13.1.5.3 Recent developments 191
13.1.5.3.1 Deals 191
13.1.5.3.2 Expansion 191
13.1.5.4 MnM view 191
13.1.5.4.1 Key strengths/Right to win 191
13.1.5.4.2 Strategic choices 192
13.1.5.4.3 Weaknesses/Competitive threats 192
13.1.6 BIOSENSORS INTERNATIONAL GROUP, LTD. 193
13.1.6.1 Business overview 193
13.1.6.2 Products/Solutions/Services offered 193
13.1.6.3 Recent developments 194
13.1.6.3.1 Product approvals 194
13.1.7 CYTIVA 195
13.1.7.1 Business overview 195
13.1.7.2 Products/Solutions/Services offered 195
13.1.7.3 Recent developments 196
13.1.7.3.1 Deals 196
13.1.8 DEXCOM, INC. 197
13.1.8.1 Business overview 197
13.1.8.2 Products/Solutions/Services offered 198
13.1.8.3 Recent developments 198
13.1.8.3.1 Product launches 198
13.1.9 LIFESCAN IP HOLDINGS, LLC 199
13.1.9.1 Business overview 199
13.1.9.2 Products/Solutions/Services offered 199
13.1.10 MASIMO 200
13.1.10.1 Business overview 200
13.1.10.2 Products/Solutions/Services offered 201
13.1.10.3 Recent developments 201
13.1.10.3.1 Deals 201
13.1.11 NOVA BIOMEDICAL 202
13.1.11.1 Business overview 202
13.1.11.2 Products/Solutions/Services offered 202
13.1.11.3 Recent developments 203
13.1.11.3.1 Deals 204
13.1.12 UNIVERSAL BIOSENSORS 205
13.1.12.1 Business overview 205
13.1.12.2 Products/Solutions/Services offered 207
13.2 OTHER PLAYERS 208
13.2.1 ACON LABORATORIES 208
13.2.2 CONDUCTIVE TECHNOLOGIES 209
13.2.3 EASTPRINT INCORPORATED 210
13.2.4 IST AG 211
13.2.5 LIFESIGNALS 212
13.2.6 NEUROSKY 213
13.2.7 PINNACLE TECHNOLOGY 214
13.2.8 SD BIOSENSOR, INC. 215
13.2.9 VITALCONNECT 216
13.2.10 XSENSIO 217
13.2.11 ZIMMER AND PEACOCK 218
13.2.12 PARAGRAF LIMITED 219
13.2.13 DYNAMIC BIOSENSORS 219
13.2.14 LINEXENS 220
13.2.15 BIOLINQ INCORPORATED 220
14 APPENDIX 221
14.1 DISCUSSION GUIDE 221
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 224
14.3 CUSTOMIZATION OPTIONS 226
14.4 RELATED REPORTS 226
14.5 AUTHOR DETAILS 227
LIST OF TABLES
TABLE 1 BIOSENSORS MARKET: RESEARCH ASSUMPTIONS 36
TABLE 2 ROLE OF COMPANIES IN BIOSENSOR ECOSYSTEM 52
TABLE 3 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEMS,
BY PRODUCT TYPE (USD), 2025 54
TABLE 4 INDICATIVE SELLING PRICE OF GLUCOSE MONITORING SYSTEMS, BY COMPANY (USD), 2025 55
TABLE 5 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEM,
BY REGION, 2021–2024 (USD) 55
TABLE 6 BIOSENSORS MARKET: LIST OF MAJOR PATENTS 62
TABLE 7 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 65
TABLE 8 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 66
TABLE 9 BIOSENSORS MARKET: PORTER’S FIVE FORCES ANALYSIS 68
TABLE 10 BIOSENSORS MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FOR TOP 3 APPLICATIONS (%) 69
TABLE 11 BIOSENSORS MARKET: KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 70
TABLE 12 BIOSENSORS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 71
TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 73
TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 74
TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 17 NORTH AMERICA: SAFETY STANDARDS FOR BIOSENSORS 74
TABLE 18 EUROPE: SAFETY STANDARDS FOR BIOSENSORS 75
TABLE 19 ASIA PACIFIC: SAFETY STANDARDS FOR BIOSENSORS 75
TABLE 20 REST OF THE WORLD: SAFETY STANDARDS FOR BIOSENSORS 75
TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES 76
TABLE 22 BIOSENSORS MARKET, BY TYPE, 2021–2024 (USD MILLION) 83
TABLE 23 BIOSENSORS MARKET, BY TYPE, 2025–2030 (USD MILLION) 83
TABLE 24 BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 86
TABLE 25 BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 86
TABLE 26 BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (MILLION UNITS) 87
TABLE 27 BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (MILLION UNITS) 87
TABLE 28 WEARABLE BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 88
TABLE 29 WEARABLE BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 88
TABLE 30 WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 88
TABLE 31 WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 89
TABLE 32 WEARABLE BIOSENSORS MARKET, BY TYPE, 2021–2024 (USD MILLION) 89
TABLE 33 WEARABLE BIOSENSORS MARKET, BY TYPE, 2025–2030 (USD MILLION) 89
TABLE 34 NON-WEARABLE BIOSENSORS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 92
TABLE 35 NON-WEARABLE BIOSENSORS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 92
TABLE 36 NON-WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY,
2021–2024 (USD MILLION) 92
TABLE 37 NON-WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY,
2025–2030 (USD MILLION) 93
TABLE 38 BIOSENSORS MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 95
TABLE 39 BIOSENSORS MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 95
TABLE 40 ELECTROCHEMICAL BIOSENSORS MARKET, BY PRODUCT,
2021–2024 (USD MILLION) 96
TABLE 41 ELECTROCHEMICAL BIOSENSORS MARKET, BY PRODUCT,
2025–2030 (USD MILLION) 96
TABLE 42 OPTICAL BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 99
TABLE 43 OPTICAL BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 99
TABLE 44 PIEZOELECTRIC BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 100
TABLE 45 PIEZOELECTRIC BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 101
TABLE 46 THERMAL BIOSENSORS MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 102
TABLE 47 THERMAL BIOSENSORS MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 102
TABLE 48 NANOMECHANICAL BIOSENSORS MARKET, BY PRODUCT,
2021–2024 (USD MILLION) 103
TABLE 49 NANOMECHANICAL BIOSENSORS MARKET, BY PRODUCT,
2025–2030 (USD MILLION) 103
TABLE 50 BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 105
TABLE 51 BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 106
TABLE 52 BIOSENSORS MARKET FOR POC APPLICATIONS, BY TYPE,
2021–2024 (USD MILLION) 107
TABLE 53 BIOSENSORS MARKET FOR POC APPLICATIONS, BY TYPE,
2025–2030 (USD MILLION) 107
TABLE 54 BIOSENSORS MARKET FOR POC APPLICATIONS, BY PRODUCT,
2021–2024 (USD MILLION) 107
TABLE 55 BIOSENSORS MARKET FOR POC APPLICATIONS, BY PRODUCT,
2025–2030 (USD MILLION) 108
TABLE 56 BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION,
2021–2024 (USD MILLION) 108
TABLE 57 BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION,
2025–2030 (USD MILLION) 108
TABLE 58 NORTH AMERICA: BIOSENSORS MARKET FOR POC APPLICATIONS,
BY COUNTRY, 2021–2024 (USD MILLION) 108
TABLE 59 NORTH AMERICA: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 109
TABLE 60 EUROPE: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY,
2021–2024 (USD MILLION) 109
TABLE 61 EUROPE: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY,
2025–2030 (USD MILLION) 109
TABLE 62 ASIA PACIFIC: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 110
TABLE 63 ASIA PACIFIC: BIOSENSORS MARKET FOR POC APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 110
TABLE 64 REST OF THE WORLD: BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 110
TABLE 65 REST OF THE WORLD: BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 110
TABLE 66 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY TYPE,
2021–2024 (USD MILLION) 113
TABLE 67 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY TYPE,
2025–2030 (USD MILLION) 114
TABLE 68 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY PRODUCT, 2021–2024 (USD MILLION) 114
TABLE 69 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY PRODUCT, 2025–2030 (USD MILLION) 114
TABLE 70 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 114
TABLE 71 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 115
TABLE 72 NORTH AMERICA: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 115
TABLE 73 NORTH AMERICA: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 115
TABLE 74 EUROPE: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS,
BY COUNTRY, 2021–2024 (USD MILLION) 115
TABLE 75 EUROPE: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS,
BY COUNTRY, 2025–2030 (USD MILLION) 116
TABLE 76 ASIA PACIFIC: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS,
BY COUNTRY, 2021–2024 (USD MILLION) 116
TABLE 77 ASIA PACIFIC: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS,
BY COUNTRY, 2025–2030 (USD MILLION) 116
TABLE 78 REST OF THE WORLD: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 117
TABLE 79 REST OF THE WORLD: BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 117
TABLE 80 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY PRODUCT,
2021–2024 (USD MILLION) 118
TABLE 81 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY PRODUCT,
2025–2030 (USD MILLION) 118
TABLE 82 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION,
2021–2024 (USD MILLION) 119
TABLE 83 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION,
2025–2030 (USD MILLION) 119
TABLE 84 NORTH AMERICA: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS,
BY COUNTRY, 2021–2024 (USD MILLION) 119
TABLE 85 NORTH AMERICA: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS,
BY COUNTRY, 2025–2030 (USD MILLION) 119
TABLE 86 EUROPE: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 120
TABLE 87 EUROPE: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 120
TABLE 88 ASIA PACIFIC: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS,
BY COUNTRY, 2021–2024 (USD MILLION) 120
TABLE 89 ASIA PACIFIC: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS,
BY COUNTRY, 2025–2030 (USD MILLION) 121
TABLE 90 REST OF THE WORLD: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 121
TABLE 91 REST OF THE WORLD: BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 121
TABLE 92 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS,
BY PRODUCT, 2021–2024 (USD MILLION) 122
TABLE 93 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS,
BY PRODUCT, 2025–2030 (USD MILLION) 122
TABLE 94 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS,
BY REGION, 2021–2024 (USD MILLION) 122
TABLE 95 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS,
BY REGION, 2025–2030 (USD MILLION) 123
TABLE 96 NORTH AMERICA: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 123
TABLE 97 NORTH AMERICA: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 123
TABLE 98 EUROPE: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 123
TABLE 99 EUROPE: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 124
TABLE 100 ASIA PACIFIC: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 124
TABLE 101 ASIA PACIFIC: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 124
TABLE 102 REST OF THE WORLD: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 125
TABLE 103 REST OF THE WORLD: BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 125
TABLE 104 BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY PRODUCT, 2021–2024 (USD MILLION) 126
TABLE 105 BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY PRODUCT, 2025–2030 (USD MILLION) 126
TABLE 106 BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY REGION,
2021–2024 (USD MILLION) 126
TABLE 107 BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY REGION,
2025–2030 (USD MILLION) 126
TABLE 108 NORTH AMERICA: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 127
TABLE 109 NORTH AMERICA: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 127
TABLE 110 EUROPE: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS,
BY COUNTRY, 2021–2024 (USD MILLION) 127
TABLE 111 EUROPE: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS,
BY COUNTRY, 2025–2030 (USD MILLION) 128
TABLE 112 ASIA PACIFIC: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS,
BY COUNTRY, 2021–2024 (USD MILLION) 128
TABLE 113 ASIA PACIFIC: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS,
BY COUNTRY, 2025–2030 (USD MILLION) 128
TABLE 114 REST OF THE WORLD: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY REGION, 2021–2024 (USD MILLION) 129
TABLE 115 REST OF THE WORLD: BIOSENSORS MARKET FOR FOOD & BEVERAGE APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 129
TABLE 116 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY PRODUCT,
2021–2024 (USD MILLION) 129
TABLE 117 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY PRODUCT,
2025–2030 (USD MILLION) 130
TABLE 118 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY REGION,
2021–2024 (USD MILLION) 130
TABLE 119 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY REGION,
2025–2030 (USD MILLION) 130
TABLE 120 NORTH AMERICA: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS,
BY COUNTRY, 2021–2024 (USD MILLION) 130
TABLE 121 NORTH AMERICA: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS,
BY COUNTRY, 2025–2030 (USD MILLION) 131
TABLE 122 EUROPE: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY COUNTRY, 2021–2024 (USD MILLION) 131
TABLE 123 EUROPE: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY COUNTRY, 2025–2030 (USD MILLION) 131
TABLE 124 ASIA PACIFIC: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS,
BY COUNTRY, 2021–2024 (USD MILLION) 132
TABLE 125 ASIA PACIFIC: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS,
BY COUNTRY, 2025–2030 (USD MILLION) 132
TABLE 126 REST OF THE WORLD: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS,
BY REGION, 2021–2024 (USD MILLION) 132
TABLE 127 REST OF THE WORLD: BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS,
BY REGION, 2025–2030 (USD MILLION) 132
TABLE 128 BIOSENSORS MARKET, BY REGION, 2021–2024 (USD MILLION) 134
TABLE 129 BIOSENSORS MARKET, BY REGION, 2025–2030 (USD MILLION) 135
TABLE 130 NORTH AMERICA: BIOSENSORS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 136
TABLE 131 NORTH AMERICA: BIOSENSORS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 137
TABLE 132 NORTH AMERICA: BIOSENSORS MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 137
TABLE 133 NORTH AMERICA: BIOSENSORS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 137
TABLE 134 EUROPE: BIOSENSORS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 140
TABLE 135 EUROPE: BIOSENSORS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 141
TABLE 136 EUROPE: BIOSENSORS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 141
TABLE 137 EUROPE: BIOSENSORS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 141
TABLE 138 ASIA PACIFIC: BIOSENSORS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 144
TABLE 139 ASIA PACIFIC: BIOSENSORS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 145
TABLE 140 ASIA PACIFIC: BIOSENSORS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 145
TABLE 141 ASIA PACIFIC: BIOSENSORS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 145
TABLE 142 REST OF THE WORLD: BIOSENSORS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 147
TABLE 143 REST OF THE WORLD: BIOSENSORS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 147
TABLE 144 REST OF THE WORLD: BIOSENSORS MARKET, BY REGION,
2021–2024 (USD MILLION) 147
TABLE 145 REST OF THE WORLD: BIOSENSORS MARKET, BY REGION,
2025–2030 (USD MILLION) 148
TABLE 146 MIDDLE EAST: BIOSENSORS MARKET, BY REGION, 2021–2024 (USD MILLION) 148
TABLE 147 MIDDLE EAST: BIOSENSORS MARKET, BY REGION, 2025–2030 (USD MILLION) 149
TABLE 148 GCC COUNTRIES: BIOSENSORS MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 149
TABLE 149 GCC COUNTRIES: BIOSENSORS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 149
TABLE 150 BIOSENSORS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2024 151
TABLE 151 BIOSENSORS MARKET SHARE ANALYSIS, 2024 154
TABLE 152 BIOSENSORS MARKET: REGION FOOTPRINT 161
TABLE 153 BIOSENSORS MARKET: PRODUCT FOOTPRINT 162
TABLE 154 BIOSENSORS MARKET: TYPE FOOTPRINT 163
TABLE 155 BIOSENSORS MARKET: TECHNOLOGY FOOTPRINT 164
TABLE 156 BIOSENSORS MARKET: APPLICATION FOOTPRINT 165
TABLE 157 BIOSENSORS MARKET: LIST OF KEY START-UPS/SMES 168
TABLE 158 BIOSENSORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 168
TABLE 159 BIOSENSORS MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021–MAY 2025 169
TABLE 160 BIOSENSORS MARKET: DEALS, JANUARY 2021–MAY 2025 170
TABLE 161 BIOSENSORS MARKET: EXPANSIONS, JANUARY 2021–MAY 2025 172
TABLE 162 ABBOTT LABORATORIES: COMPANY OVERVIEW 173
TABLE 163 ABBOTT LABORATORIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 174
TABLE 164 ABBOTT LABORATORIES: PRODUCT ENHANCEMENTS, JANUARY 2021–MAY 2025 175
TABLE 165 ABBOTT LABORATORIES: DEALS, JANUARY 2021–MAY 2025 176
TABLE 166 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW 178
TABLE 167 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 179
TABLE 168 F. HOFFMANN-LA ROCHE LTD: DEALS, JANUARY 2021–MAY 2025 180
TABLE 169 MEDTRONIC: COMPANY OVERVIEW 182
TABLE 170 MEDTRONIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 183
TABLE 171 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–MAY 2025 184
TABLE 172 MEDTRONIC: DEALS, JANUARY 2021–MAY 2025 184
TABLE 173 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 186
TABLE 174 BIO-RAD LABORATORIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 187
TABLE 175 DUPONT: COMPANY OVERVIEW 189
TABLE 176 DUPONT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 190
TABLE 177 DUPONT: DEALS, JANUARY 2021–MAY 2025 191
TABLE 178 DUPONT: EXPANSIONS, JANUARY 2021–MAY 2025 191
TABLE 179 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW 193
TABLE 180 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS/SOLUTIONS/
SERVICES OFFERED 193
TABLE 181 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCT APPROVALS,
JANUARY 2021–MAY 2025 194
TABLE 182 CYTIVA: COMPANY OVERVIEW 195
TABLE 183 CYTIVA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 195
TABLE 184 CYTIVA: DEALS, JANUARY 2021–MAY 2025 196
TABLE 185 DEXCOM, INC.: COMPANY OVERVIEW 197
TABLE 186 DEXCOM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 198
TABLE 187 DEXCOM, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 198
TABLE 188 LIFESCAN IP HOLDINGS, LLC: COMPANY OVERVIEW 199
TABLE 189 LIFESCAN IP HOLDINGS, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 199
TABLE 190 MASIMO: COMPANY OVERVIEW 200
TABLE 191 MASIMO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 201
TABLE 192 MASIMO: DEALS, JANUARY 2021–MAY 2025 201
TABLE 193 NOVA BIOMEDICAL: COMPANY OVERVIEW 202
TABLE 194 NOVA BIOMEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 202
TABLE 195 NOVA BIOMEDICAL: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 203
TABLE 196 NOVA BIOMEDICAL: DEALS, JANUARY 2021–MAY 2025 204
TABLE 197 UNIVERSAL BIOSENSORS: COMPANY OVERVIEW 205
TABLE 198 UNIVERSAL BIOSENSORS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 207
LIST OF FIGURES
FIGURE 1 BIOSENSORS MARKET SEGMENTATION 24
FIGURE 2 BIOSENSORS MARKET: RESEARCH DESIGN 27
FIGURE 3 BIOSENSORS MARKET: BOTTOM-UP APPROACH 33
FIGURE 4 BIOSENSORS MARKET SIZE ESTIMATION METHODOLOGY 34
FIGURE 5 BIOSENSORS MARKET: TOP-DOWN APPROACH 34
FIGURE 6 BIOSENSORS MARKET: DATA TRIANGULATION 35
FIGURE 7 BIOSENSOR MARKET FOR SENSOR PATCHES TO GROW AT HIGHER CAGR
DURING FORECAST PERIOD 38
FIGURE 8 WEARABLE BIOSENSORS TO GROW AT HIGHER RATE DURING FORECAST PERIOD 39
FIGURE 9 ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2030 39
FIGURE 10 POC APPLICATIONS TO HOLD LARGEST SHARE OF BIOSENSORS MARKET 40
FIGURE 11 BIOSENSORS MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR FROM 2025 TO 2030 41
FIGURE 12 RISING DEMAND FOR WEARABLE DEVICES TO DRIVE USE OF BIOSENSORS IN POC AND HOME DIAGNOSTIC APPLICATIONS 42
FIGURE 13 WRISTWEAR APPLICATION TO HOLD LARGEST SHARE OF WEARABLE BIOSENSORS MARKET THROUGHOUT FORECAST PERIOD 42
FIGURE 14 US AND NON-WEARABLE DEVICES TO HOLD LARGEST SHARE OF NORTH AMERICAN BIOSENSORS MARKET IN 2025 43
FIGURE 15 BIOSENSORS MARKET IN CHINA TO GROW AT HIGHEST CAGR
FROM 2025 TO 2030 43
FIGURE 16 BIOSENSORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 44
FIGURE 17 BIOSENSORS MARKET: DRIVERS AND THEIR IMPACT 45
FIGURE 18 BIOSENSORS MARKET: RESTRAINTS AND THEIR IMPACT 47
FIGURE 19 BIOSENSORS MARKET: OPPORTUNITIES AND THEIR IMPACT 48
FIGURE 20 BIOSENSORS MARKET: CHALLENGES AND THEIR IMPACT 49
FIGURE 21 BIOSENSORS MARKET: VALUE CHAIN ANALYSIS 50
FIGURE 22 BIOSENSORS MARKET: ECOSYSTEM 52
FIGURE 23 BIOSENSORS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 53
FIGURE 24 AVERAGE SELLING PRICE OF GLUCOSE MONITORING SYSTEMS,
BY COMPANY, 2025 (USD) 54
FIGURE 25 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEM,
BY REGION, 2021–2024 55
FIGURE 26 INVESTMENT AND FUNDING SCENARIO, 2023–2025 59
FIGURE 27 IMPACT OF GEN AI/AI ON BIOSENSORS MARKET 60
FIGURE 28 BIOSENSORS MARKET: PATENTS APPLIED AND GRANTED, 2014–2024 61
FIGURE 29 IMPORT DATA FOR PRODUCTS COVERED UNDER HS CODE 901890, BY COUNTRY, 2020–2025 (USD THOUSAND) 64
FIGURE 30 EXPORT DATA FOR PRODUCTS COVERED UNDER HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 66
FIGURE 31 BIOSENSORS MARKET: PORTER’S FIVE FORCES ANALYSIS 67
FIGURE 32 BIOSENSORS MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 69
FIGURE 33 BIOSENSORS MARKET: KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 70
FIGURE 34 SENSOR PATCHES TO GROW AT HIGHER CAGR DURING FORECAST PERIOD 83
FIGURE 35 MARKET FOR WEARABLE BIOSENSORS TO GROW AT HIGHER RATE DURING FORECAST PERIOD 86
FIGURE 36 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2030 95
FIGURE 37 POC APPLICATIONS HELD LARGEST MARKET SHARE OF BIOSENSORS
MARKET IN 2025 105
FIGURE 38 NORTH AMERICA HOLDS LARGEST SHARE OF BIOSENSORS MARKET 134
FIGURE 39 NORTH AMERICA: BIOSENSORS MARKET SNAPSHOT 136
FIGURE 40 EUROPE: BIOSENSORS MARKET SNAPSHOT 140
FIGURE 41 ASIA PACIFIC: BIOSENSORS MARKET SNAPSHOT 144
FIGURE 42 REVENUE ANALYSIS OF TOP 5 PLAYERS, 2022–2024 152
FIGURE 43 MARKET SHARE ANALYSIS OF TOP 5 PLAYERS, 2024 153
FIGURE 44 COMPANY VALUATION 156
FIGURE 45 FINANCIAL METRICS (EV/EBITDA) 156
FIGURE 46 BIOSENSORS MARKET: BRAND/PRODUCT COMPARISON 157
FIGURE 47 BIOSENSORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 159
FIGURE 48 BIOSENSORS MARKET: COMPANY FOOTPRINT 160
FIGURE 49 BIOSENSORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 167
FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT 174
FIGURE 51 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT 179
FIGURE 52 MEDTRONIC: COMPANY SNAPSHOT 183
FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 187
FIGURE 54 DUPONT: COMPANY SNAPSHOT 190
FIGURE 55 DEXCOM, INC.: COMPANY SNAPSHOT 197
FIGURE 56 MASIMO: COMPANY SNAPSHOT 200
FIGURE 57 UNIVERSAL BIOSENSORS: COMPANY SNAPSHOT 206
